Merck & Co a convenit să achiziţioneze Prometheus Biosciences cu aproximativ 10,8 miliarde de dolari
Merck & Co a convenit să achiziţioneze Prometheus Biosciences pentru aproximativ 10,8 miliarde de dolari, pentru a consolida prezenţa companiei în imunologie, au declarat duminică cele două companii, transmite Reuters, potrivit News.ro.
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2013/09/medicamente.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2011/10/pastila_20518700-535x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/11/screenshot_2020_09_16_at_09_43_56_79529400-752x420.png)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/05/nelu2_85998100_35721700.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/03/ana_tower_46501100-630x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2015/06/procter_gamble_4567_14164100.JPG)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2013/02/merck_06065500.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2012/04/bvb_90714100_51376600.jpg)
